dr. eyre discusses venetoclax monotherapy in mcl
Published 6 years ago • 86 plays • Length 1:26Download video MP4
Download video MP3
Similar videos
-
0:56
dr. eyre on results of venetoclax in relapsed/refractory mcl
-
1:52
dr. eyre on btk inhibitors in combination with venetoclax for mcl
-
1:39
venetoclax monotherapy in mcl: longer-term results
-
1:03
dr. wang discusses promise of venetoclax in mcl
-
3:27
venetoclax: an unmet need in r/r mantle cell lymphoma after btk inhibitors
-
2:38
toby eyre | would venetoclax monotherapy be a good option for r/r mcl post-btk inhibitor therapy?
-
1:10
dr. eyre on resistance to btk inhibition in mcl
-
2:06
the role of venetoclax in r/r mcl & options for patients who progress on venetoclax
-
1:09
dr. goy discusses ibrutinib with venetoclax in mcl
-
1:08
dr. tam on the toxicities of ibrutinib plus venetoclax in mcl
-
1:09
dr. ritchie on the immunologic impact of long-term venetoclax/ibrutinib in r/r mcl
-
1:08
dr. tam on the toxicity of ibrutinib plus venetoclax in mcl
-
1:27
dr. rule on the combination of venetoclax and ibrutinib in mcl
-
1:27
dr. ritchie on immunological response to venetoclax/ibrutinib in r/r mcl
-
1:16
dr. shah on excitement with venetoclax in patients with mcl
-
1:22
dr. kaplan on the combination of ibrutinib and venetoclax in mcl
-
3:42
acalabrutinib plus venetoclax and rituximab in mcl & the importance of chemotherapy-free regimens
-
1:21
ibrutinib, rituximab and venetoclax in the treatment of patients with newly diagnosed mcl
-
1:43
ongoing clinical trials to look out for in lymphoma